Overview
Estrogen therapy, with or without a progestogen (progesterone and progestin), has long been prescribed to treat menopausal symptoms. It has been extensively studied, and it is the most consistently effective therapy for vasomotor symptoms.
Data from numerous studies suggest that oral, transdermal, or vaginal hormone therapy reduces the severity of hot flashes by 65-90%.
Estrogen, a steroid hormone, is derived from the androgenic precursors androstenedione and testosterone by means of aromatization. In order of potency, naturally occurring estrogens are 17 (beta)-estradiol (E2), estrone (E1), and estriol (E3). The synthesis and actions of these estrogens are complex.
In brief, these forms of estrogen can be summarized as follows:
Estradiol – Primarily produced by theca and granulosa cells of the ovary; it is the predominant form of estrogen found in premenopausal women
Estrone – Formed from estradiol in a reversible reaction; this is the predominant form of circulating estrogen after menopause; estrone is also a product of the peripheral conversion of androstenedione secreted by the adrenal cortex
Estriol – The estrogen the placenta secretes during pregnancy; in addition, it is the peripheral metabolite of estradiol and estrone; it is not secreted by the ovary
Table 1 summarizes normal concentrations of the various estrogens.
Table 1. Production and Concentrations of Estrogens in Healthy Women
(Open Table in a new window)
Phase |
17b-Estradiol |
Estrone |
Estriol |
|||
Serum Concentration, pg/mL |
Daily Production, mg |
Serum Concentration, pg/mL |
Daily Production, mg |
Serum Concentration, pg/mL |
Daily Production, mg |
|
Follicular |
40-200 |
60-150 |
30-100 |
50-100 |
3-11 |
6-23 |
Preovulatory |
250-500 |
200-400 |
50-200 |
200-350 |
– |
– |
Luteal |
100-150 |
150-300 |
50-115 |
120-250 |
6-16 |
12-30 |
Premenstrual |
40-50 |
50-70 |
15-40 |
30-60 |
– |
– |
Postmenstrual |
< 20 |
5-25 |
15-80 |
30-80 |
3-11 |
5-22 |
Estrogens affect many different systems, organs, and tissues, including the liver, bone, skin, gastrointestinal (GI) tract, breast, uterus, vasculature, and central nervous system (CNS). These effects appear to become most prominent during times of estrogen deficiency, such as the menopausal transition.